The Antidepressant Clomipramine Regulates Cortisol Intracellular Concentrations and Glucocorticoid Receptor Expression in Fibroblasts and Rat Primary Neurones
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Incubation of LMCAT fibroblasts cells with antidepressants potentiates glucocorticoid receptor (GR)-mediated gene transcription in the presence of cortisol, but not of corticosterone. We have suggested that antidepressants do so by inhibiting the LMCAT cells membrane steroid transporter and thus by increasing cortisol intracellular concentrations. We now confirm and extend this model to primary neuronal cultures. Clomipramine, a tricyclic antidepressant, increased the intracellular accumulation of 3H-cortisol, but not 3H-corticosterone, in LMCAT cells (+80%) and primary rat neurones (+20%). The latter finding is the first demonstration that a membrane steroid transporter is present in neurones. Moreover, verapamil, a membrane steroid transporter inhibitor, reduced the effects of clomipramine on the intracellular accumulation of 3H-cortisol in LMCAT cells. Finally, clomipramine also decreased GR expression (whole-cell Western blot) in LMCAT cells (50% reduction) and primary rat neurones (80% reduction). This GR downregulation can explain the reduced GR-mediated gene transcription previously described under experimental conditions that do not elicit the effects on the LMCAT cells steroid transporter. This work further supports the hypothesis that membrane steroid transporters regulating the access of glucocorticoids to the brain in vivo are a fundamental target for antidepressant action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an extensive literature, some from our own group, which shows that antidepressants directly regulate the function of the glucocorticoid receptor (GR).18, 19, 20, 21, 22, 23, 24”
From Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor (2011) · cites this paper as [23]
In the citing paper
“Studies by us and others have shown that antidepressants also induce GR nuclear translocation and transactivation, which is, at least in part, mediated by the cyclic AMP (cAMP)/protein kinase A (PKA) cascade.21, 22, 23, 24, 30, 31, 32, 33”
From Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor (2011) · cites this paper as [23]
In the citing paper
“This is in line with reports from the literature in both cell culture and animal studies,23, 51, 61”
From Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor (2011) · cites this paper as [23]
In the citing paper
“probably results from the increased GR transactivation.19, 23, 24”
From Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor (2011) · cites this paper as [23]
Citations
Cites
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 7×
“…GR (and MR) expression, enhance GR function and promote GR nuclear translocation; this, in turn, is associated with enhanced GR-mediated negative feedback by endogenous glucocorticoids, and thus with reduced resting and stimulated HPA axis activity (Holsboer, 2000; Pariante and Miller, 2001).”
BackgroundResultInfluentialSelf-citationMcEwen, B. S., Biron, C. A., Brunson, K. W., Bulloch, K., Chambers, W. H., Dhabhar, F. S., Goldfarb, R. H., Kitson, R. P., Miller, A. H., Spencer, R. L., et al. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00012-4 · Cited by 837 · cited 2×
“…of the GR from the cytoplasm to the nucleus (Pariante et al, 1997), and this is associated with a decrease of GR in the cytosolic fraction (McEwen et al, 1997), we had interpreted the desipramine-induced decrease in GR binding as representing a greater proportion of GR in the nucleus…”
BackgroundHuman P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., & Hori, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35757-0 · Cited by 673
(1996) · PubMed · Cited by 547
Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations
Lee, G., Dallas, S., Hong, M., & Bendayan, R. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01513-8 · Cited by 539
Neurotrophic and Neuroprotective Actions of Estrogens and Their Therapeutic Implications
Lee, S. J., & McEwen, B. S. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.569 · Cited by 534
Sisodiya, S. M., Lin, W. ‐., Harding, B. N., Squier, M. V., & Thom, M. (2002) · Brain · doi:10.1093/brain/awf002 · Cited by 479
Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters
Leslie, E. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00454-1 · Cited by 376
Meijer, O. C. (1998) · Endocrinology · doi:10.1210/en.139.4.1789 · Cited by 375
Maes, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357
Reul, J. M. (1993) · Endocrinology · doi:10.1210/en.133.1.312 · Cited by 345
Karssen, A. M. (2001) · Endocrinology · doi:10.1210/en.142.6.2686 · Cited by 280
Regina, A., Koman, A., Piciotti, M., El Hafny, B., Center, M. S., Bergmann, R., Couraud, P., & Roux, F. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020705.x · Cited by 266
Uhr, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00095-0 · Cited by 244
Williamson, R., Scales, T., Clark, B. R., Gibb, G., Reynolds, C. H., Kellie, S., Bird, I. N., Varndell, I. M., Sheppard, P. W., Everall, I., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00010.2002 · Cited by 227 · cited 2×
“The procedures for Western blotting and densitometry image analysis were previously described (Williamson et al, 2002).”
MethodSelf-citationUhr, M., Holsboer, F., & Müller, M. B. (2002) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2002.00836.x · Cited by 207
Ekins, S., Kim, R. B., Leake, B. F., Dantzig, A. H., Schuetz, E. G., Lan, L.-B., Yasuda, K., Shepard, R. L., Winter, M. A., Schuetz, J. D., et al. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12192-x · Cited by 191
Modulation of glucocorticoid receptor function by protein kinase A
Rangarajan, P. N. (1992) · Molecular Endocrinology · doi:10.1210/me.6.9.1451 · Cited by 168
Ford, J. M. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00047-0 · Cited by 164
Pariante, C. M., Makoff, A., Lovestone, S., Feroli, S., Heyden, A., Miller, A. H., & Kerwin, R. W. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704368 · Cited by 159 · cited 20×
“Clomipramine directly reduces cell metabolic activity only at concentrations of 100 mM or higher (Pariante et al, 2001a), while cortisol does not influence cell metabolic activity for concentrations ranging 10 nM–1 mM.”
BackgroundMethodInfluentialSelf-citationSteroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine
Pariante, C. M., Pearce, B. D., Pisell, T. L., Owens, M. J., & Miller, A. H. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.4.571 · Cited by 156 · cited 11×
“Finally, preincubation of cells with an antidepressant (for up to 5 days) leads to approximately 50% inhibition of GR-mediated gene transcription induced by a subsequent short treatment (1.5–2 h) with dexamethasone or corticosterone (Pariante et al, 1997; Budziszewska et al, 2000).”
BackgroundMethodResultInfluentialSelf-citationPépin, M.-C., Beaulieu, S., & Barden, N. (1989) · Molecular Brain Research · doi:10.1016/0169-328x(89)90031-4 · Cited by 151
Hirrlinger, J., König, J., & Dringen, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01082.x · Cited by 131
Kralli, A., & Yamamoto, K. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17152 · Cited by 125
Felix, R. A., & Barrand, M. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00660.x · Cited by 123
Risk factors for suicide attempts among African American women
Kaslow, N., Thompson, M., Meadows, L., Chance, S., Puett, R., Hollins, L., Jessee, S., & Kellermann, A. (2000) · Depression and Anxiety · doi:10.1002/1520-6394(2000)12:1<13::aid-da2>3.0.co;2-y · Cited by 119
Bourgeois, S. (1993) · Molecular Endocrinology · doi:10.1210/me.7.7.840 · Cited by 113
DeBattista, C., Posener, J. A., Kalehzan, B. M., & Schatzberg, A. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.8.1334 · Cited by 113
Increased glucocorticoid receptor gene promoter activity after antidepressant treatment.
Pepin, M. C., Govindan, M. V., & Barden, N. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09226-0 · Cited by 113
Budziszewska, B., Jaworska‐Feil, L., Kajta, M., & Lasoń, W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703445 · Cited by 110
The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone
Karssen, A., Meijer, O., van der Sandt, I., De Boer, A., De Lange, E., & De Kloet, E. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750251 · Cited by 110
Developmental expression of p-glycoprotein (multidrug resistance gene product) in the rat brain
Matsuoka, Y., Okazaki, M., Kitamura, Y., & Taniguchi, T. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19990605)39:3<383::aid-neu5>3.0.co;2-4 · Cited by 107
Glotzbach, R. K., & Preskorn, S. (1982) · Psychopharmacology · doi:10.1007/bf00470582 · Cited by 106
Xia, Z., Bergstrand, A., DePierre, J. W., & N�ssberger, L. (1999) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7 · Cited by 98
Beck, C. A. (1993) · Endocrinology · doi:10.1210/en.133.2.728 · Cited by 93
Okugawa, Omori, Suzukawa, Fujiseki, Kinoshita, T., & Inagaki, C. (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00405.x · Cited by 92
P‐glycoprotein transports corticosterone and is photoaffinity‐labeled by the steroid
Wolf, D. C., & Horwitz, S. B. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520125 · Cited by 91
Dexamethasone augmentation in treatment‐resistant depression
Dinan, T. G., Lavelle, E., Cooney, J., Burnett, F., Scott, L., Dash, A., Thakore, J., & Berti, C. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00374.x · Cited by 84
A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis
Pariante, C. M., Papadopoulos, A. S., Poon, L., Checkley, S. A., English, J., Kerwin, R. W., & Lightman, S. L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01314-2 · Cited by 78
Self-citationAutoregulation of corticosteroid receptors. How, when, where, and why?
Schmidt, T. J., & Meyer, A. S. (1994) · PubMed · Cited by 77
Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock
Sanchez, E. R. (1994) · Molecular Endocrinology · doi:10.1210/me.8.4.408 · Cited by 71
Chen, J., & Rasenick, M. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020724.x · Cited by 70
Lai, M., McCormick, J. A., Chapman, K. E., Kelly, P. A. T., Seckl, J. R., & Yau, J. L. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00038-1 · Cited by 65
The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function
Miller, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00381-0 · Cited by 57 · cited 7×
“…blocking of steroid transport can increase the intracellular levels of steroids from the mediaFeven steroid stripping of serum cannot be absolute (Miller et al, 2002)Fthus leading to translocation of the GR. Data showing that PGP inhibitors induce partial GR translocation support this…”
BackgroundInfluentialPariante, C., Pearce, B., Pisell, T., Su, C., & Miller, A. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690309 · Cited by 57
Self-citationNorepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant
Rossby, S. P., Nalepa, I., Huang, M., Perrin, C., Burt, A. M., Schmidt, D. E., Gillespie, D. D., & Sulser, F. (1995) · Brain Research · doi:10.1016/0006-8993(95)00459-4 · Cited by 56
Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo
Szabó, D., Szabó, G., Ocsovszki, I., Aszalós, A., & Molnár, J. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00020-8 · Cited by 56
Blom, J. M. C., Tascedda, F., Carra, S., Ferraguti, C., Barden, N., & Brunello, N. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00401-8 · Cited by 52
Molecular and pharmacological strategies to overcome multidrug resistance
Shabbits, J. A., Krishna, R., & Mayer, L. D. (2001) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.1.4.585 · Cited by 51
Rifampicin Is Not an Activator of Glucocorticoid Receptor
Herr, A. S., Wochnik, G., Rosenhagen, M. C., Holsboer, F., & Rein, T. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.4.732 · Cited by 49
Kwan, P., Sills, G. J., Butler, E., Gant, T. W., Meldrum, B. S., & Brodie, M. J. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.156702.x · Cited by 48
Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds
Prima, V., Depoix, C. L., Masselot, B., Formstecher, P., & Lefèbvre, P. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00146-6 · Cited by 47
Bouwer, C., Claassen, J., Dinan, T. G., & Nemeroff, C. B. (2000) · Depression and Anxiety · doi:10.1002/1520-6394(2000)12:1<44::aid-da6>3.0.co;2-c · Cited by 46
O’Donnell, D., Francis, D. D., Weaver, S., & Meaney, M. J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00479-a · Cited by 44
Merry, S. P., Hamilton, T. G., Flanigan, P., Freshney, R. I., & Kaye, S. B. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90054-h · Cited by 43
Yau, J. L. W., Noble, J., Hibberd, C., & Seckl, J. R. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01890-0 · Cited by 43
Brain distribution and kinetics of desipramine in the rat
Hrdina, P. D., & Dubas, T. C. (1981) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y81-027 · Cited by 42
Regulation of glucocorticoidreceptor-mRNA in human blood cells by amitriptyline and dexamethasone
Vedder, H., Bening-Abu-Shach, U., Lanquillon, S., & Krieg, J. C. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00006-0 · Cited by 40
Pariante, C. M., Pearce, B. D., Pisell, T. L., Sanchez, C. I., Po, C., Su, C., & Miller, A. H. (1999) · Endocrinology · doi:10.1210/en.140.9.4359 · Cited by 40
Self-citationPrzegaliński, E., Budziszewska, B., Siwanowicz, J., & Jaworska, L. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90036-3 · Cited by 39
Héry, M., Sémont, A., Fache, M., Faudon, M., & Héry, F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740406.x · Cited by 34
Castaing, M., Brouant, P., Loiseau, A., Santelli-Rouvier, C., Santelli, M., Alibert-Franco, S., Mahamoud, A., & Barbe, J. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001773977 · Cited by 32
Reversal of multidrug resistance by amitriptyline in vitro.
Varga, A., Nugel, H., von Baehr, R., Marx, U., Hevér, A., Nacsa, J., Ocsovszky, I., & Molnár, J. (1996) · PubMed · Cited by 31
Marsaud, V., Mercier-Bodard, C., Fortin, D., Bihan, S. L., & Renoir, J. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00008-9 · Cited by 30
Medh, R. D., Lay, R. H., & Schmidt, T. J. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00055-0 · Cited by 30
A whole-cell assay for glucocorticoid binding sites in normal human lymphocytes.
Steiner, A. E., & Wittliff, J. L. (1985) · Clinical Chemistry · doi:10.1093/clinchem/31.11.1855 · Cited by 26
Hatakeyama, M., & Matsumura, F. (1999) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/(sici)1099-0461(1999)13:6<316::aid-jbt5>3.0.co;2-o · Cited by 24
Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells
Bergman, A. M., Pinedo, H. M., & Peters, G. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00858-5 · Cited by 24
Kurowski, C., & Berthold, F. (1998) · Annals of Oncology · doi:10.1023/a:1008476528846 · Cited by 21
Multidrug resistance-modifying components in human plasma with potential clinical significance.
MÜLDER, H. S., Pinedo, H. M., At, T., Rao, B. R., & Lankelma, J. (1996) · PubMed · Cited by 12
Brooksbank, B. W. L., Brammall, M. A., & Shaw, D. M. (1973) · PubMed · Cited by 9
Cited by
Monoamine neurocircuitry in depression and strategies for new treatments
Hamon, M., & Blier, P. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.009 · Cited by 594
The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?
Anacker, C., Zunszain, P. A., Carvalho, L. A., & Pariante, C. M. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.007 · Cited by 592
“It is a common finding that around 50% of depressed patients (80% if severely depressed) show hyperactivity of the HPA axis (Young et al., 1991; Holsboer, 2000; Pariante and Miller, 2001; Pariante, 2003).”
BackgroundSelf-citationCattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K. J., Craig, I. W., Anacker, C., Zunsztain, P. A., McGuffin, P., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.191 · Cited by 436
“Of note, we have consistently shown that antidepressants regulate the function and the expression of the GR (Jurena et al, 2010; Pariante et al, 1997, 2003, 2004, 2012; Pariante and Miller, 2001).”
BackgroundSelf-citationAntidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor
Anacker, C., Zunszain, P. A., Cattaneo, A., Carvalho, L. A., Garabedian, M. J., Thuret, S., Price, J., & Pariante, C. M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.26 · Cited by 435
Self-citationPariante, C. M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.04.001 · Cited by 382
“We found that, in vitro, these effects are common to all tested antidepressants and are present not only in mouse fibroblasts but also in rat neurons (Pariante et al., 2001, 2003a. 2003b, 2004b).”
Self-citation
Metadata
- Authors
- Pariante, C. M., Hye, A., Williamson, R., Makoff, A., Lovestone, S., & Kerwin, R. W.
- Affiliations
- King's College London (GB)
- Corresponding author
- Pariante, Carmine M
- Venue
- Neuropsychopharmacology
- Published
- 2003-03-12
- Volume
- 28
- Issue
- 9
- Pages
- 1553-1561
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2051773374
- Cited by
- 70
- References
- 71
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2020: 1 · 2017: 6 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 5 · 2012: 2
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Emory University
- National Alliance for Research on Schizophrenia and Depression
- Wellcome Trust
- School of Medicine, Emory University
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- clomipramine, tricyclic antidepressants, glucocorticoid receptor, corticosterone, verapamil, antidepressant mechanism
- MeSH terms
- Animals, Antidepressive Agents, Tricyclic, Cells, Cultured, Cerebral Cortex, Clomipramine, Corticosterone, Densitometry, Dose-Response Relationship, Drug, Drug Interactions, Embryo, Mammalian, Extracellular Space, Fibroblasts, Hydrocortisone, Neurons, Receptors, Glucocorticoid, Tritium, Blotting, Western, Down-Regulation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.